Transgene Biotek Profile
Key Indicators
- Authorised Capital ₹ 76.00 Cr
- Paid Up Capital ₹ 75.77 Cr
- Company Age 35 Year, 11 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.03 Cr
- Satisfied Charges ₹ 3.92 Cr
- Revenue Growth -22.98%
- Profit Growth 42.24%
- Ebitda -127.08%
- Net Worth -3049.61%
- Total Assets -12.74%
About Transgene Biotek
Transgene Biotek Limited. (TBL) is a Public Limited Indian Non-Government Company incorporated in India on 01 March 1990 and has a history of 35 years. Its registered office is in Medak, Telangana, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 526139.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 76.00 Cr and a paid-up capital of Rs 75.77 Cr.
The company currently has active open charges totaling ₹11.03 Cr. The company has closed loans amounting to ₹3.92 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Transgene Biotek Limited. India are Chowdari Prasad as CFO and Ankita Jain as Company Secretary. Kollipara Rao, Santhosh Kumar, Sujana Kadiam, and One other member serve as directors at the Company.
Company Details
- Location
Medak, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L85195TG1990PLC011065
- Company No.
011065
- Stock Symbol
BSE : 526139
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Mar 1990
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Hyderabad
Industry
Life Sciences
Who are the key members and board of directors at Transgene Biotek?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kollipara Rao  | Managing Director | 04-Mar-2020 | Current |
| Chowdari Prasad | CFO | 24-May-2019 | Current |
| Ankita Jain | Company Secretary | 24-May-2019 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swetha Marri | Director | 03-Jun-2020 | Current |
| Santhosh Kumar | Director | 12-Nov-2019 | Current |
| Sujana Kadiam | Director | 17-Apr-2015 | Current |
Financial Performance of Transgene Biotek.
Transgene Biotek Limited., for the financial year ended 2023, experienced significant reduction in revenue, with a 22.98% decrease. The company also saw a substantial improvement in profitability, with a 42.24% increase in profit. The company's net worth observed a substantial decline by a decrease of 3049.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Transgene Biotek?
In 2023, Transgene Biotek had a promoter holding of 21.68% and a public holding of 78.32%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sanghi Spinners India LimitedSanthosh Kumar is a mutual person
Neodel Pharma Private LimitedKollipara Rao is a mutual person
- Niedlfree Technologies Private Limited
Kollipara Rao is a mutual person
- Pfl Infotech Limited
Sujana Kadiam is a mutual person
Charges (Loans)
Open Charges
₹11.03 Cr
Satisfied Charges
₹3.92 Cr
Charges Breakdown by Lending Institutions
- Department Of Biotechnology : 5.07 Cr
- Industrial Development Bank Of India : 4.28 Cr
- Ankot Tradesec Ltd. : 0.70 Cr
- The Karur Vysya Bank Ltd. : 0.59 Cr
- State Bank Of India : 0.30 Cr
- Others : 0.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Apr 2010 | Department Of Biotechnology | ₹5.07 Cr | Open |
| 30 Jul 2008 | Ge Capital Services India | ₹0.86 M | Open |
| 30 May 2005 | The Karur Vysya Bank Ltd. | ₹5.94 M | Open |
| 20 Oct 1996 | Ankot Tradesec Ltd. | ₹7.00 M | Open |
| 17 Jun 1993 | State Bank Of India | ₹3.00 M | Open |
How Many Employees Work at Transgene Biotek?
Unlock and access historical data on people associated with Transgene Biotek, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Transgene Biotek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Transgene Biotek's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Transgene Biotek
Recent activity within the organization
- Annual General Meeting
Transgene Biotek Limited. last Annual general meeting of members was held on 30 Dec 2023 as per latest MCA records.
- Balance Sheet
Transgene Biotek Limited. has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Charges
A charge registered on 23 May 2007 via Charge ID 10052981 with Union Bank Of India was fully satisfied on 25 May 2021.
- Director Appointment
Swetha Marri was appointed as a Director was appointed as a Director on 03 Jun 2020 & has been associated with this company since 4 years 9 months .
- Director Appointment
Kollipara Koteswara Rao was appointed as a Managing Director was appointed as a Managing Director on 04 Mar 2020 & has been associated with this company since 5 years 7 days .
- Director Appointment
Santhosh Kumar was appointed as a Director was appointed as a Director on 12 Nov 2019 & has been associated with this company since 5 years 4 months .
Recent News, Updates & Announcement
Fund Diversion Case: SEBI restricts Transgene Biotek, 6 others from securities market.Besides, Transgene will continue the measures to recall the outstanding amount of USD 38.5 million and bring the money back into its bank account in India within a period of one year from the date... .
- Transgene: A Positive 2018, Moving Ahead with a Strong Portfolio.
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies to transform the fight against solid tumors and infectious diseases, publishes its financial results for 2018 and provides an update on its clinical and preclinical portfolio, and its technology platforms..
- GDR issue: Sebi lifts market ban on Transgene Biotek's 2 promoters, director.
The latest ruling comes after Securities and Exchange Board of India (Sebi) in November 2014, had ordered a detailed probe in this regard. .
Frequently asked questions
What is the Incorporation or founding date of Transgene Biotek Limited.?
Transgene Biotek Limited. was incorporated on 01 Mar 1990.
What is authorized share capital and paid-up capital of Transgene Biotek Limited.?
The authorized share capital of Transgene Biotek Limited. is ₹ 76.00 Cr and paid-up capital is ₹ 75.77 Cr.
Who are the current board members & directors of Transgene Biotek Limited.?
Currently 6 directors are associated with Transgene Biotek Limited..
- Kollipara Koteswara Rao
- Santhosh Kumar
- Chowdari Prasad
- Ankita Jain
- Sujana Kadiam
- Swetha Marri
What is the registered address of Transgene Biotek Limited.?
As per Ministry of Corporate Affairs (Mca), the registered address of Transgene Biotek Limited. is Plot No:69 70, Sangareddy District. Bollaram India, Ida Bollaram, Telangana, 502325.
What is the corporate identification number (CIN) and company number of Transgene Biotek Limited.?
The corporate identification number (CIN) of Transgene Biotek Limited. is L85195TG1990PLC011065 and the company number is 011065 as per Ministry of Corporate Affairs (MCA).
Is Transgene Biotek Limited. registered with any stock exchange in India?
Yes, Transgene Biotek Limited. is registered on Bombay Stock Exchange (BSE).
What is the official website of Transgene Biotek Limited.?
The Official website of Transgene Biotek Limited. is https://www.transgenebiotek.com
What has been the recent revenue trend for Transgene Biotek Limited.?
According to the financial reports for the fiscal year 2023, the revenue trend for Transgene Biotek Limited. has fallen by -22.98%.
What change has been observed in the net worth of Transgene Biotek Limited., and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Transgene Biotek Limited. has experienced an downturn of -3049.61%.
What are the total open charges for Transgene Biotek Limited.?
As per the financial statements for fiscal Year 2023, The total open charges for Transgene Biotek Limited. amount to ₹ 11.03 Cr.
When was the last Balance Sheet of Transgene Biotek Limited. filed with the ROC?
The most recent Balance Sheet for Transgene Biotek Limited. was filed with the ROC on 31 Mar 2023.
People also Viewed
Puranik SubhashDirectorSM
Soma MarthiDirectorSN
Sri NuthalapatiDirectorPG
Prasanta GhoshDirectorPV
Polavarapu VikramManaging DirectorPV
Paradesi VaishaliDirectorSD
Shyam DasDirectorNP
Narayana PentyalaDirector